Cingulate (CING) had its price target lowered by Ascendiant Capital Markets from $58.00 to $55.00. They now have a "buy" rating on the stock.
Cingulate (CING) had its price target lowered by Roth Mkm from $16.00 to $14.00. They now have a "buy" rating on the stock.
Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights [Yahoo! Finance]
Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules